Concepedia
Statistics
Publications
22
Citations
2.1K
H-Index
15
Active since
1987
Affiliations
Levine Cancer Institute(Current)
Washington University in St. Louis
Fred Hutch Cancer Center
Sarcoma Oncology Center
Duke Medical Center
Michael B. Livingston is an author at Levine Cancer Institute specializing in oncology, medicine, and radiation oncology.
Top concepts
MedicineOncologyRadiation OncologyPathologyCancer TherapyHealthCancer ResearchSurgical OncologyMolecular OncologyClinical Trials
Publications per year
1987–2022
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
William D. Tap, Robin L. Jones, Brian A. Van Tine et al. · The Lancet · 2016 · 582 citations
Surgical Oncology, Oncology, Soft-tissue Sarcoma +7
Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
Robert G. Maki, David R. D’Adamo, Mary Louise Keohan et al. · Journal of Clinical Oncology · 2009 · 569 citations · Full text
Surgical Oncology, Sarcoma Subtype, Malignant Disease +13
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma
Lara E. Davis, Vanessa Bolejack, Christopher W. Ryan et al. · Journal of Clinical Oncology · 2019 · 251 citations · Full text
Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial
Gary K. Schwartz, William D. Tap, Li-Xuan Qin et al. · The Lancet Oncology · 2013 · 186 citations · Full text
SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors
Christine S. Higham, Seth M. Steinberg, Eva Dombi et al. · Sarcoma · 2017 · 90 citations · Full text
1–5 of 22